Hepatocyte nuclear factor 4α Isoforms originated from the P1 promoter are expressed in human pancreatic β-cells and exhibit stronger transcriptional potentials than P2 promoter-driven isoforms

被引:74
作者
Eeckhoute, J
Moerman, E
Bouckenooghe, T
Lukoviak, B
Pattou, F
Formstecher, P
Kerr-Conte, J
Vandewalle, B
Laine, B [1 ]
机构
[1] Fac H Warembourg, INSERM, U459, F-59045 Lille, France
[2] Fac H Warembourg, Diabetes Cell Therapy Unit, ERIM 106, INSERM, F-59045 Lille, France
关键词
D O I
10.1210/en.2002-0024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The nuclear receptor hepatocyte nuclear factor (HNF) 4alpha is involved in a transcriptional network and plays an important role in pancreatic beta-cells. Mutations in the HNF4alpha gene are correlated with maturity-onset diabetes of the young 1. HNF4alpha isoforms result from both alternative splicing and alternate usage of promoters P1 and P2. It has recently been reported that HNF4alpha transcription is driven almost exclusively by the P2 promoter in pancreatic islets. We observed that transcripts from both P1 and P2 promoters were expressed in human pancreatic beta-cells and in the pancreatic beta-cell lines RIN m5F and HIT-T15. Expression of HNF4alpha proteins originating from the P1 promoter was confirmed by immunodetection. Due to the presence of the activation function module AF-1, HNF4alpha isoforms originating from the P1 promoter exhibit stronger transcriptional activities and recruit coactivators more efficiently than isoforms driven by the P2 promoter. Conversely, activities of isoforms produced by both promoters were similarly repressed by the corepressor small heterodimer partner. These behaviors were observed on the promoter of HNF1alpha that is required for beta-cell function. Our results highlight that expression of P1 promoter-driven isoforms is important in the control of pancreatic beta-cell function.
引用
收藏
页码:1686 / 1694
页数:9
相关论文
共 46 条
[1]   Hepatocyte nuclear factor-1α recruits the transcriptional co-activator p300 on the GLUT2 gene promoter [J].
Ban, N ;
Yamada, Y ;
Someya, Y ;
Miyawaki, K ;
Ihara, Y ;
Hosokawa, M ;
Toyokuni, S ;
Tsuda, K ;
Seino, Y .
DIABETES, 2002, 51 (05) :1409-1418
[2]   Activation of the insulin gene promoter through a direct effect of hepatocyte nuclear factor 4α [J].
Bartoov-Shifman, R ;
Hertz, R ;
Wang, HY ;
Wollheim, CB ;
Bar-Tana, J ;
Walker, MD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (29) :25914-25919
[3]   A transcription factor regulatory circuit in differentiated pancreatic cells [J].
Boj, SF ;
Párrizas, M ;
Maestro, MA ;
Ferrer, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (25) :14481-14486
[4]   Two regulatory elements of similar structure and placed in tandem account for the repressive activity of the first intron of the human apolipoprotein A-II gene [J].
Bossu, JP ;
Chartier, FL ;
Fruchart, JC ;
Auwerx, J ;
Staels, B ;
Laine, B .
BIOCHEMICAL JOURNAL, 1996, 318 :547-553
[5]   CLONING AND SEQUENCING OF CDNAS ENCODING THE HUMAN HEPATOCYTE NUCLEAR FACTOR 4 INDICATE THE PRESENCE OF 2 ISOFORMS IN HUMAN LIVER [J].
CHARTIER, FL ;
BOSSU, JP ;
LAUDET, V ;
FRUCHART, JC ;
LAINE, B .
GENE, 1994, 147 (02) :269-272
[6]  
Drewes T, 1996, MOL CELL BIOL, V16, P925
[7]   Maturity-onset diabetes of the young type 1 (MODY1)-associated mutations R154X and E276Q in hepatocyte nuclear factor 4α (HNF4α) gene impair recruitment of p300, a key transcriptional coactivator [J].
Eeckhoute, J ;
Formstecher, P ;
Laine, B .
MOLECULAR ENDOCRINOLOGY, 2001, 15 (07) :1200-1210
[8]   Mechanisms of disease: Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. [J].
Fajans, SS ;
Bell, GI ;
Polonsky, KS .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (13) :971-980
[9]   A genetic switch in pancreatic β-cells -: Implications for differentiation and haploinsufficiency [J].
Ferrer, J .
DIABETES, 2002, 51 (08) :2355-2362
[10]   Organization and partial sequence of the hepatocyte nuclear factor-4 alpha MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY [J].
Furuta, H ;
Iwasaki, N ;
Oda, N ;
Hinokio, Y ;
Horikawa, Y ;
Yamagata, K ;
Yano, N ;
Sugahiro, J ;
Ogata, M ;
Ohgawara, H ;
Omori, Y ;
Iwamoto, Y ;
Bell, GI .
DIABETES, 1997, 46 (10) :1652-1657